(R)-2-((3R,5R,7R)-ADamantan-1-Yl)-2-((Tert-Butoxycarbonyl)Amino)Acetic Acid

Catalog No. :
ACTEHQ783
CAS No. :
1564266-26-7
Molecular Formula :
C17H27NO4
Molecular Weight :
309.41

IUPAC Name:(2R)-2-(adamantan-1-yl)-2-((tert-butoxycarbonyl)amino)acetic acid

(R)-2-((3R,5R,7R)-ADamantan-1-Yl)-2-((Tert-Butoxycarbonyl)Amino)Acetic Acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$879.00Login to see priceInquiryInquiry
1g95%$1760.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-2-((3R,5R,7R)-ADamantan-1-Yl)-2-((Tert-Butoxycarbonyl)Amino)Acetic Acid
IUPAC Name(2R)-2-(adamantan-1-yl)-2-((tert-butoxycarbonyl)amino)acetic acid
MDL No.MFCD23135956
Molecular FormulaC17H27NO4
Molecular Weight309.41
SMILESO=C(O)[C@@H](C12CC3CC(C2)CC(C3)C1)NC(OC(C)(C)C)=O
InChI KeyLJUATQZYDYSZPV-RQYMUSGFSA-N
Synonym(R)-2-((3R,5R,7R)-Adamantan-1-Yl)-2-((Tert-Butoxycarbonyl)Amino)Acetic Acid(WX125330);(R)-2-((3R,5R,7R)-Adamantan-1-Yl)-2-((Tert-Butoxycarbonyl)Amino)Acetic Acid;(2R)-2-(1-adamantyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid;Tricyclo[3.3.1.13,7]decane-1-acetic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-, (αR)-;(R)-2-(adamantan-1-yl)-2-((tert-butoxycarbonyl)amino)acetic acid;(R)-2-(Boc-amino)-2-(adamantan-1-yl)acetic acid
CAS No.1564266-26-7

Synthetic Route by SureRoute

1. ACTEHQ783 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTEHQ783 route product structure diagram
    ACTEHQ7831564266-26-7
Inquiry

2. ACTEHQ783 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTEHQ783 route product structure diagram
    ACTEHQ7831564266-26-7
Inquiry

Comments (0)